SNCA and Parkinson disease: The upregulation of retrotransposons and certain PD-related genes including SNCA following complex I inhibition may constitute inadvertent side-effects of the physiologically purposeful, but pleiotropic induction of mito-metabolic genes via epigenetic chromatin remodeling.